Renaissance Technologies - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 2 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2023$4,591
-39.8%
179,700
-32.4%
0.01%
-27.3%
Q2 2023$7,620
-99.2%
265,700
+895.6%
0.01%
+1000.0%
Q4 2021$988,000
-1.0%
26,687
-9.5%
0.00%0.0%
Q2 2021$998,000
-83.1%
29,500
-79.3%
0.00%
-85.7%
Q1 2021$5,898,000
+2231.2%
142,800
+512.9%
0.01%
Q4 2019$253,000
-24.3%
23,300
-28.3%
0.00%
Q3 2019$334,00032,5000.00%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q4 2023
NameSharesValueWeighting ↓
SEVEN EIGHT CAPITAL, LP 46,819$2,031,0000.47%
Orbimed Advisors 1,206,886$49,844,0000.47%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 25,000$1,033,0000.40%
ARK Investment Management 3,331,889$137,607,0000.27%
FEDERATED HERMES, INC. 3,203,000$132,284,0000.26%
MGO ONE SEVEN LLC 26,990$1,114,0000.19%
Koss-Olinger Consulting, LLC 20,000$826,0000.14%
Jump Financial, LLC 35,400$1,462,0000.14%
Graham Capital Management, L.P. 74,262$3,067,0000.14%
New England Research & Management, Inc. 6,005$248,0000.14%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders